Inventor
Tanja Denise DE GRUIJL
Inventor
NL
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07KPeptides25%
C12NMicroorganisms or enzymes6%
C12YEnzymes6%
PatentTitleYear
12,233,096Recombinant replication competent viruses comprising a coding region for glycogen synthase kinase-3 (GSK3) and methods of killing aberrant cells202512,110,328Single domain antibodies targeting CD1d202412,077,586Bispecific antibodies for use in the treatment of hematological malignancies202411,591,394Single domain antibodies targeting CD1d202311,384,145Immunoglobulins binding human Vg9Vd2 T cell receptors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to LAVA THERAPEUTICS N V (4)· patent assignee history
2022–2025Based in NL· patent location history
2025Patents assigned to ORCA THERAPEUTICS B V (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LAVA THERAPEUTICS N V | 4 | 2022–2024 |
| ORCA THERAPEUTICS B V | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| NL | 5 | 2022–2025 |